Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Opinion in Pulmonary Medicine|July 15, 2022
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guideAgustín Roberto García, Lucilla PiccariPulmonary Circulation|June 27, 2024
Pulmonary vascular disease, environmental pollution, and climate changeMona Lichtblau, Lena Reimann, Lucilla PiccariRespirology (Carlton, Vic.)|March 31, 2016
Pulmonary vasculature in COPD: The silent componentIsabel Blanco, Lucilla Piccari, Joan Albert BarberàCurrent Opinion in Pulmonary Medicine|July 3, 2023
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?Lucilla Piccari, Ricardo Aguilar-Colindres, Diego A Rodríguez-ChiaradíaArchivos De Bronconeumologia|October 12, 2014
Differences in clinical features of two immigrant populations with tuberculosisAugust Supervía, Oriol Pallàs, Lucilla Piccari, et al.Pulmonary Circulation|December 29, 2022
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionSteven D Nathan, Peter Fernandes, Mitchell Psotka, et al.BMJ Open Respiratory Research|October 10, 2025
Effects of pulmonary arterial hypertension therapies on arterial oxygenation in patients with pulmonary hypertension associated with lung disease: a systematic review and meta-analysisIsabel Blanco, Rodrigo Torres-Castro, Lucilla Piccari, et al.Journal of Medical Genetics|March 22, 2019
Genetic linkage analysis of a large family identifies FIGN as a candidate modulator of reduced penetrance in heritable pulmonary arterial hypertensionPau Puigdevall, Lucilla Piccari, Isabel Blanco, et al.Biomedicines|September 28, 2021
Iron Replacement and Redox Balance in Non-Anemic and Mildly Anemic Iron Deficiency COPD Patients: Insights from a Clinical TrialMaria Pérez-Peiró, Clara Martín-Ontiyuelo, Anna Rodó-Pi, et al.Pulmonary Circulation|January 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionOksana A Shlobin, Eric Shen, Stephen J Wort, et al.Pageof 3